Lexaria Bioscience Corp (LEXX)

[Shawking]

Although sulforaphane has good bioavailability and can cross the blood-brain barrier it's not very stable and this is probably why SulfoSyn has sought out LEXX.
"The use of such extracts, though effective, is complicated by the fact that sulforaphane is only moderately stable over time, especially in aqueous solution. The reactivity of sulforaphane is exacerbated by the fact that lyophilized extracts are hygroscopic, and as water is adsorbed during protracted storage or formulation, their useful shelf-life is limited unless chemically stabilized, kept cold, or made frequently during the study."
Or treated with DehydraTECH!
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629881/